Celltrion Plans EU Filing For Remsima SC As Phase III Completed

 
• By Jung Won Shin
  
Celltrion Headquarters
Celltrion Plans EU Filing For SC Formulation Of Infliximab Biosimilar • Source: Celltrion Inc.

More from New Products

More from Scrip